|
2024
|
Invention
|
Treatment for rheumatoid arthritis.
The present invention provides anti-GM-CSF antibodies for us... |
|
|
Invention
|
Clinical assessment of m-protein response in multiple myeloma.
Applicant discloses an anti-idiot... |
|
|
Invention
|
Dual-targeting of flt3 and cd123 co-expressing tumor cells by functional complementation of cycat... |
|
|
Invention
|
T cell receptor beta constant region 2 (trbc2) antibodies. The present disclosure provides novel ... |
|
|
Invention
|
Il-13 receptor alpha 2 binding polypeptides. The present invention relates to polypeptides that a... |
|
|
Invention
|
Antibodies targeting c5ar.
The present invention provides novel antibodies or antibody fragments... |
|
|
Invention
|
Generation and profiling of fully human therapeutic antibodies specific for human cd38.
The pres... |
|
2023
|
Invention
|
Antibodies specific for human complement c5a receptor (c5ar). The present invention provides nove... |
|
|
Invention
|
Therapy comprising anti-cd19 antibody and ezh2 modulators. The present disclosure provides method... |
|
|
Invention
|
Combination therapy comprising sirp alpha fusion protein and anti-cd19 antibody for treatment of ... |
|
|
Invention
|
Complex-specific antibodies and antibody fragments and its use.
The present invention provides a... |
|
|
Invention
|
Deimmunized antibodies specific for cd3. The present invention provides affinity optimized and de... |
|
2022
|
Invention
|
Treatment paradigm for an anti-cd19 antibody therapy. The present disclosure provides anti-CD19 a... |
|
|
Invention
|
Methods for reducing anti-cd38 mab drug interference in serological assays. The present invention... |
|
|
Invention
|
Therapy comprising anti-cd19 antibody and sumo-activating enzyme inhibitor. The present disclosur... |
|
|
Invention
|
Combinations of antigen binding molecules. The present disclosure provides combinations or sets o... |
|
|
Invention
|
Treatment of anti-pla2r autoantibody-mediated membranous nephropathy.
The present disclosure rel... |
|
|
Invention
|
Treatment of anti-pla2r autoantibody-mediated membranous nephropathy. The present disclosure rela... |
|
|
P/S
|
Reagents for scientific and medical research for use in the
research and production of small mol... |
|
|
P/S
|
Reagents for scientific and medical research for use in the research and production of small mole... |
|
|
Invention
|
Anti-cd38 antibodies for use in the treatment of antibody-mediated transplant rejection.
The pre... |
|
|
Invention
|
Anti-cd38 antibodies for use in the treatment of antibody-mediated transplant rejection. The pres... |
|
|
Invention
|
Anti-cd38 antibodies and their uses.
The present invention relates to the use of an anti-CD38 an... |
|
|
Invention
|
Anti-cd38 antibodies and their uses. The present invention relates to the use of an anti-CD38 ant... |
|
|
Invention
|
Fab molecules with a rodent hinge region and a non-rodent ch1 region.
The disclosure relates to ... |
|
2021
|
Invention
|
Anti-cd19 combination therapy. The present disclosure is directed to a therapeutic combination of... |
|
|
P/S
|
antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; Biol... |
|
|
P/S
|
Biological and biotechnological products used in industry and science; Biological preparations fo... |
|
|
P/S
|
reagents for scientific and medical research for use in the research and production of small mole... |
|
|
Invention
|
Novel human antibodies binding to human cd3 epsilon.
The present disclosure provides novel fully... |
|
|
Invention
|
Novel human antibodies binding to human cd3 epsilon. The present disclosure provides novel fully ... |
|
|
Invention
|
Combination therapies targeting c5ar and pd-1/pd-l1 pathways. Provided are compositions and thera... |
|
|
Invention
|
Anti-tumor combination therapy comprising anti-cd19 antibody and polypeptides blocking the sirp?-... |
|
|
Invention
|
Anti-tumor combination therapy comprising anti-cd19 antibody and polypeptides blocking the sirpα-... |
|
|
Invention
|
Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for hu... |
|
|
Invention
|
Anti-gm-csf antibodies.
The present invention provides recombinant antigen-binding regions, anti... |
|
2020
|
Invention
|
Method to increase antibody yield during ion exchange chromatography.
The present invention rela... |
|
|
Invention
|
Eluate collection during antibody chromatography.
The present invention relates to an improved m... |
|
|
Invention
|
Eluate collection during antibody chromatography. The present invention relates to an improved me... |
|
|
Invention
|
Method to increase antibody yield during ion exchange chromatography. The present invention relat... |
|
|
Invention
|
Anti-cd38 antibodies and pharmaceutical compositions thereof for the treatment of autoantibody-me... |
|
2019
|
Invention
|
Antibody formulations.
The present disclosure relates to formulations of a pharmaceutically acti... |
|
|
Invention
|
Multispecific antigen-binding molecules.
Novel antigen-binding molecules are provided, with the ... |
|
|
P/S
|
Antibodies for scientific purposes and not for medical or veterinary use; Monoclonal antibodies f... |
|
|
Invention
|
Antibodies targeting glycoprotein vi. The present disclosure provides antibodies or antibody frag... |
|
|
P/S
|
Antibodies for scientific purposes, other than for medical or veterinary use; Monoclonal antibodi... |
|
2018
|
Invention
|
Treatment of atopic dermatitis.
The present invention provides a pharmaceutical composition comp... |
|
2016
|
P/S
|
Chemical, biochemical, biological and biotechnological products used in industry and science; bio... |
|
2012
|
P/S
|
Chemicals used in industry and science, as well as in agriculture and horticulture; biochemical, ... |
|
2011
|
P/S
|
Chemical, biochemical, biological and biotechnological preparations, namely, antibodies and fragm... |
|
2010
|
P/S
|
Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies and frag... |
|
|
P/S
|
Antibodies and fragments of antibodies for use in the development or manufacture of immunological... |
|
2008
|
P/S
|
Pharmaceutical preparations and substances for the treatment of cancer, inflammatory diseases, Al... |
|
2006
|
P/S
|
[ Chemical, biochemical,] biological, [ and biotechnological ] preparations for use in the develo... |
|
|
P/S
|
[ Chemical, biochemical, biological, and biotechnological preparations for use in the development... |
|
|
P/S
|
[Chemicals for use in industry, science, agriculture, horticulture and forestry, namely, carrier ... |
|
|
P/S
|
Chemicals used in industry, science, agriculture, horticulture and forestry; in particular carrie... |
|
2002
|
P/S
|
CHEMICAL, BIOCHEMICAL, BIOLOGICAL, AND BIOTECHNOLOGICAL PREPARATIONS, NAMELY, ANTIBODIES AND FRAG... |
